Lupin is a buy: Vikas Khemani, Edelweiss Securities Ltd

Vikas Khemani, Executive Vice President & Head - Institutional Equities, Edelweiss Securities Ltd, in a chat with ET Now talks about the pharma stocks.

What is your high conviction investment idea?

I am quite bullish on the pharma space. So I would look to buy names like Cadila Healthcare, Lupin. So pharma space -from a medium term to long term perspective - is a very good space and there is a reasonably good amount of growth visibilitym especially in the domestic market space.

Also, stocks are not very expensive if you compare with similar kind of business model like consumer sector or IT. Pharma looks very interesting.